PALATIN TECHNOLOGIES, INC. Proceeds from Long-Term Debt Issued
PALATIN TECHNOLOGIES, INC. (PTN) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2018-06-30, per its 10-K filed 2018-09-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2018-09-13
- PALATIN TECHNOLOGIES, INC. proceeds from issuance of long-term debt for fiscal 2018 was $0.00.
- PALATIN TECHNOLOGIES, INC. proceeds from issuance of long-term debt for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- PALATIN TECHNOLOGIES, INC. proceeds from issuance of long-term debt for fiscal 2016 was $10.00M, a 0.00% change from fiscal 2015.
- PALATIN TECHNOLOGIES, INC. proceeds from issuance of long-term debt for fiscal 2015 was $10.00M.
| Period end | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|
| 2018-06-30 | $0.00 10-K · filed 2018-09-13 | |
| 2017-06-30 | $0.00 10-K · filed 2018-09-13 | |
| 2016-06-30 | $10.00M 10-K · filed 2018-09-13 | |
| 2015-06-30 | $10.00M 10-K · filed 2017-09-25 | |
| 2014-12-31 | $10.00M 10-Q · filed 2015-02-12 | |
| 2014-06-30 | $0.00 10-K · filed 2016-09-19 | |
| 2013-12-31 | $0.00 10-Q · filed 2015-02-12 | |
| 2013-06-30 | $0.00 10-K · filed 2015-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |